No Data
No Data
Antivenoms Global Market Insights and Outlook 2024-2030: A $2.3 Billion Opportunity With Snake Antivenoms Accounting for ~87% Share of the Total Market - BTG PLC Leads the Competition, Followed by CSL Ltd.
2 ASX 200 Retirement Shares to Buy Now
If you are in the process of building a retirement portfolio, then you may want to check out the quality ASX 200 shares listed below.
CSL Shares (ASX:CSL) Hit New 52-Week High On Strong Day For ASX 200
Shares of CSL Ltd (ASX: CSL), one of Australia’s leading biotechnology companies, have soared to a new 52-week high, marking a significant milestone. Today, the ASX 200 Index also achieved a record pinnacle, hitting an all-time high of 8,037.3 points, with shares across the board, including those of CSL Ltd, climbing by 0.73%.
CSL Shares Hit New 52-week High! What's Next?
The ASX's third-largest stock also saw its shares at a fresh new high today, albeit a 52-week one.
AU Morning Wrap: ASX 200 to Cross 8,000 for the First Time; Miners BHP, Fortescue Rally
The ASX 200 is poised to cross 8,000 for the first time, while the Dow tops 40,000, and investors are piling into small caps.
CSL Shares: 'Healthy Growth at a Reasonable Price'
CSL Ltd (ASX: CSL) shares could be a great option for growth investors right now.
No Data